Bharat Biotech: Expert committee approves Bharat Biotech Internationals proposal to conduct Phase-2 trials of TB vaccine: Sources

The Subject Expert Committee (SEC), which comes under the Central Drug Standard Control Organisation (CDSCO), has approved vaccine major Bharat Biotech Internationals proposal to conduct the Phase II clinical trials of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogenicity in healthy adolescent and adult populations.